Advertising disclosure: Vital Review may earn a commission when you use links to Maximus Tribe. Read our Advertising & Affiliate Disclosure.
Maximus Tribe review summary
Maximus Tribe describes clinician-guided weight-loss care, multi-month compounded plans and FDA-approved branded GLP-1 options. Its June help-center price chart and October weight-loss storefront advertise materially different compounded tirzepatide terms. Before paying, verify the full prepaid amount, renewal price, labs, pharmacy and cancellation rules. Vital Review has not conducted a patient purchase or clinical audit.
Service characteristics
- Comparing published plan totals and commitment lengths
- Remote cash-pay weight-management care
- Researching compounded versus branded GLP-1 options
Limitations / exclusions
- Lowest monthly equivalents require longer commitments
- Insurance billing is not available
- Users unwilling to prepay a long commitment or reconcile conflicting advertised plan prices
Maximus Tribe at a glance
- Provider type
- Cash-pay online weight-management clinic offering compounded and branded GLP-1 plans
- Starting price
- Maximus's June 2026 help guide lists a one-month compounded semaglutide first-order price of $149.99 and tirzepatide of $259.99. Its October 2026 storefront advertises different prepaid promotional rates; check exact checkout before purchase.
- Prescription
- Required
- Subscription
- Required
- Availability
- U.S. states where Maximus is authorized to provide service
- Shipping cost
- Free expedited shipping advertised on weight-loss product pages.
- Customer support
- Member portal and customer support, with clinician messaging described by the service.
- Last verified
- 2026-10-21
What this Maximus Tribe review covers
This review focuses on Maximus Tribe’s weight-loss program, including compounded GLP-1 pricing, plan commitments, clinician access, pharmacy fulfillment and cancellation terms. Original sources were checked on September 17, 2026; treatment options, public price pages, terms and screenshots were rechecked on October 21, 2026.
Service model & eligibility
- Business model
Online clinical assessment, prescription fulfillment and ongoing care via monthly brand-name plans or prepaid compounded GLP-1 commitments; pricing varies by offer and term.
- Services
- Online medical assessment
- Weight-management telehealth care
- Prescription coordination
- Member portal and clinician messaging
- Advertised conditions / use cases
- Weight management
- Programs / services
- Compounded GLP-1 weight-loss programs
- FDA-approved branded GLP-1 treatment programs
- Care / service model
Online onboarding, identity and medical-history review, clinician approval, prescription fulfillment and continuing telehealth support.
- Consultation method
Online doctor visits and messaging; exact interaction depends on protocol and state requirements.
- Eligibility / exclusions
Clinical approval and residence in a state where Maximus is authorized to provide services.
- Lab testing
Baseline or follow-up labs may be required and can cost extra. Required tests and charges should be disclosed before payment; missing labs/check-ins can affect refills.
Compounded and brand-name GLP-1s: what Maximus offers
The original review covered compounded semaglutide and tirzepatide. Maximus now also markets FDA-approved branded medicines, including Wegovy, Zepbound and Foundayo, alongside compounded treatment. These are different regulatory and pricing categories: compounded products are not FDA-approved finished medicines, even when their active ingredient is associated with an approved brand. Do not infer the clinical-trial results or exact formulation of an approved product for an individually prepared compounded prescription. See the provider’s weight-loss treatment catalog.
Maximus’s name-brand pricing guide lists the following examples for new customers. These are starting dose tiers, not universal prices for every dose or patient. A first-month discount applies to branded medicines; higher doses may require a higher-priced tier.
| Branded treatment and example tier | First month advertised | Ongoing monthly | Important distinction |
|---|---|---|---|
| Foundayo tablets (0.8 mg) | $199.99 | $299.99 | Oral branded GLP-1, with other dose tiers priced differently |
| Wegovy tablets (1.5 mg) | $249.99 | $349.99 | Daily oral semaglutide; compare with branded injections |
| Wegovy pen (0.25 mg/week) | $349.99 | $449.99 | Injection; later dose tiers can cost more |
| Zepbound pen (2.5 mg/week) | $449.99 | $549.99 | Tirzepatide injection; other strengths may cost more |
The branded plans are described as month-to-month, with no separate membership fee and medication, clinical oversight and shipping included; required labs can be extra. Maximus also lists Ozempic and Mounjaro, which it says it may prescribe off label for weight management. The appropriate medicine and approval status are clinical matters; this editorial review compares prices and service transparency, not which medicine a patient should use.
Both images were captured from Maximus’s official treatment catalog on October 21, 2026. They document advertised entry prices, not a verified personal checkout or guaranteed clinical eligibility.
Pricing & payment
- Starting price
Maximus's June 2026 help guide lists a one-month compounded semaglutide first-order price of $149.99 and tirzepatide of $259.99. Its October 2026 storefront advertises different prepaid promotional rates; check exact checkout before purchase.
- Consultation fee
Clinician consultations may be included in the selected subscription; separate laboratory or consultation charges can apply depending on protocol.
- Membership / subscription price
Varies by plan and billing term. Branded GLP-1 guide says no separate membership fee. Compounded rates may require a fully prepaid 4-, 6- or 12-month commitment; checkout controls.
- Medication pricing
Help-center reference: ongoing 1-month compounded semaglutide $249.99 and tirzepatide $359.99. Branded Foundayo $199.99 first month/$299.99 ongoing at lowest listed tier, Wegovy oral from $249.99/$349.99, Zepbound pen from $449.99/$549.99. Storefront compounded tirzepatide promotions conflict with June reference.
- Insurance
Cash-pay clinic; insurance not accepted.
- HSA / FSA
HSA/FSA eligibility is described in the help center, subject to plan rules.
- Payment methods
- Credit or debit card
- HSA/FSA eligibility described, subject to plan rules
Compounded plan pricing: first cycle versus renewal
Maximus’s June 3, 2026 help-center price schedule shows separate first-order discounted totals and standard renewal totals. The 4-, 6- and 12-month figures below are term totals payable up front, not charges automatically collected every month. These are the help-center figures, not confirmed individual checkout prices on October 21; the public storefront also shows conflicting offers, explained below.
The distinction between first-cycle promotions and renewal charges matters across providers. Our semaglutide cost comparison and tirzepatide cost comparison compare disclosed offers without equating advertised monthly equivalents with the next amount actually due.
| Plan commitment | Semaglutide: first / renewal total | Tirzepatide: first / renewal total | Renewal monthly equivalent |
|---|---|---|---|
| 1 month | $149.99 / $249.99 | $259.99 / $359.99 | $249.99 sema / $359.99 tirz |
| 4 months | $645.99 / $795.99 | $995.99 / $1,195.99 | $199 sema / $299 tirz |
| 6 months | $849.99 / $1,049.99 | $1,349.99 / $1,649.99 | $175 sema / $275 tirz |
| 12 months | $1,399.99 / $1,799.99 | $2,379.99 / $2,879.99 | $150 sema / $240 tirz |
For example, the help-center’s 12-month compounded tirzepatide first-order total of $2,379.99 works out to roughly $198.33 per month during that initial commitment, whereas a renewal total of $2,879.99 is roughly $240 monthly. Those are averages across a prepaid term, not cancellable monthly billing. The same source says multi-month plans ship in two-month batches, higher doses do not automatically change compounded-plan pricing, and California compounded semaglutide orders may carry a $50 surcharge per shipment.
Important: the Maximus pricing pages currently disagree
During our October 21, 2026 review, the live Maximus weight-loss page advertised compounded tirzepatide at $199.99/month on a two-month commitment, falling to $99.99/month on a 12-month commitment, with the entire term billed in advance and no separate introductory cycle. That is materially different from the June 3 help-center table, which quotes 12-month renewal pricing equivalent to $240/month. The available sources do not explain whether these figures belong to different campaigns, plan versions or eligibility rules. We cannot verify which applies to an individual until the final checkout terms are shown.
Before paying, obtain a written, itemized checkout confirmation showing exact treatment, initial total, minimum commitment, the price and date of renewal, number of shipments, any state fees, possible lab costs and cancellation terms. Do not assume the lowest headline figure or the older help-center table is your actual binding offer.
Longer commitments lower the monthly equivalent
Maximus publishes separate first-cycle and ongoing prices for one-, four-, six- and twelve-month compounded semaglutide and tirzepatide plans. The lowest monthly equivalents require longer commitments, while multi-month plans ship in two-month batches. A monthly equivalent should therefore not be read as a cancelable one-month price.
Medications & fulfillment
- Medications
- Compounded semaglutide
- Compounded tirzepatide
- Wegovy (oral and injection)
- Zepbound (injection)
- Foundayo (oral)
- Ozempic and Mounjaro (provider-reported off-label weight-management use)
- Pharmacy / fulfillment model
Published guides name EVR, FCC or VIOS as 503A compounded pharmacy partners by state and The Pharmacy Hub for branded medicine. Individual pharmacy assignment and licensing were not independently audited.
- Shipping / fulfillment
Monthly and prepaid commitments have different billing and shipment schedules; Maximus help center describes two-month dispensing batches for multi-month compounded plans. Actual pharmacy and transit time are not independently tested.
- Shipping cost
Free expedited shipping advertised on weight-loss product pages.
- Shipping time
Shipping cadence depends on plan; multi-month plans may ship in two-month batches.
How assessment, pharmacies, labs and delivery work
Maximus describes online medical-history intake, clinician review and prescription approval followed by dispensing through a partner pharmacy. The official care and shipping guide says laboratory results, symptoms and follow-up check-ins can affect whether a prescription or refill is approved. Account messaging is intended for nonurgent follow-up questions, not emergency care.
- Medication authorization: a paid plan or submitted questionnaire does not guarantee a prescription; clinicians determine whether treatment is appropriate.
- Dispensing: the compounded-plan pricing guide names 503A pharmacy partners EVR, FCC and VIOS depending on state; the branded-plan guide names The Pharmacy Hub. These are provider-reported arrangements, not independently audited assignments for an individual patient.
- Refills and shipping: longer compounded commitments are described as shipping every two months. Delays in required labs or follow-up may affect refill approval; an advertised delivery speed is not a promise that medical clearance happens immediately.
- Geography: the August 2026 availability guide lists Alabama, Mississippi and Louisiana as restricted for standard GLP-1 initiation, with further limitations for some microdose plans. Recheck your state and medicine at enrollment.
- Insurance and payment: the provider describes the service as cash-pay without insurance billing. An HSA/FSA card may be accepted at checkout, but reimbursement eligibility depends on the account rules and eligible expenses.
We have not ordered Maximus medication, examined a delivery, tested clinical response times or inspected its pharmacy partners. These operational details come from provider documentation and must not be presented as our firsthand findings.
Subscription terms matter as much as the headline price
Maximus states that committed multi-month plans continue through the agreed term and are generally not eligible for early termination or partial refunds. Auto-renewal can be turned off before the next term. Prescription products that have been dispensed and shipped are not returnable.
Support & policies
- Customer support
Member portal and customer support, with clinician messaging described by the service.
- Support channels
- Maximus member portal
- support@maximustribe.com
- Cancellation policy
Auto-renewal may be disabled for the next term, but stopping renewal does not cancel or refund a prepaid multi-month commitment already in effect.
- Refund policy
Generally no returns after prescription medication is dispensed and shipped. Multi-month committed terms generally lack partial refunds for early exit; defective/damaged product claims have separate procedures.
Cancellation, refunds and what the commitment actually costs
The Maximus return, refund and subscription policy distinguishes turning off auto-renewal from receiving a refund for a committed term. Auto-renewal can generally be disabled for a future billing period; a prepaid multi-month commitment normally continues until its scheduled end and is not eligible for partial refund simply because a member stops treatment early. Prescription medicine that has been dispensed and shipped is generally final sale, while damaged, incorrect or unusable shipments follow the provider’s specific claims process.
Maximus says material changes to subscription price, cadence, cancellation rights or refunds are notified in advance, and separately required labs must be disclosed before charging. Preserve a copy of the checkout terms, renewal notice and written messages. When reviewing competing GLP-1 programs, compare the total nonrefundable commitment and lab obligations as well as the headline monthly equivalent.
What independent Maximus reviews can—and cannot—tell you
The Maximus Trustpilot profile displayed approximately 1,100 reviews with a 4.4/5 TrustScore when reviewed in October 2026. Positive customer accounts often mention responsive support, onboarding or delivery; other posts describe scheduling problems, communication gaps or unexpected billing. These are individual, sometimes disputed reports and span multiple Maximus products, not necessarily its current GLP-1 plans. Trustpilot’s score is not Vital Review’s independent editorial rating and does not verify medication quality or outcomes.
Pros
- Detailed current plan pricing is publicly available
- Flat-rate dosing is described for compounded plans
- Multiple commitment lengths are published
Cons
- Multi-month commitments are generally not refundable
- Insurance is not accepted
- Order-specific pharmacy assignment was not independently verified
- Public compounded tirzepatide pricing pages show inconsistent commitment rates
Questions worth checking before subscribing
No such conclusion follows. The specific Maximus page displaying that tirzepatide figure says it is tied to a 12-month term paid in advance. Check the full dollar amount and the renewal price before authorizing payment.
No. The formulations and FDA approval status differ: compounded medicines are not FDA-approved finished drugs, whereas Zepbound is an FDA-approved branded product. Maximus lists both categories. Medical suitability and legal availability require individual professional review.
Yes, depending on the selected offer. The Maximus June help-center table lists first-order discounts with higher future renewal amounts, and its branded guide specifies a $100 discount in the first month. Meanwhile the current tirzepatide storefront advertises a different flat-rate promotion. Save the terms for the specific checkout; do not assume either promotional model applies to every plan.
They may. Required labs can be billed separately; Maximus says it does not bill insurance, and HSA/FSA treatment depends on eligibility rules. GLP-1 treatment is unavailable in some states or plans. The amount and medical pathway must be confirmed before enrollment.
Our assessment
Maximus provides unusually detailed public pricing for its current weight-loss plans, including first-cycle discounts, ongoing charges and plan-length commitments. That transparency is a strength. The main limitation is that the lowest advertised monthly equivalents are tied to longer commitments, so total financial exposure should be compared rather than headline price alone.
October 21, 2026 editorial update: We preserved the original review’s documented strengths and limitations, and added branded-treatment pricing, full commitment examples, independent customer-feedback context and screenshot evidence of an unresolved discrepancy between two Maximus pricing sources. The published category ratings are unchanged because these documents do not establish a reliable new empirical basis to rescore clinical outcomes, support quality or pharmacy fulfillment. This review is a documentary assessment, not a mystery-shopper test.
Verification & sources
Last verified:
- Maximus compounded GLP-1 June 2026 plan pricing reference (checked )
- Maximus account billing and subscriptions (checked )
- Maximus official refund and subscription terms (checked )
- Maximus Terms of Use (checked )
- Maximus FDA-approved brand GLP-1 pricing by dose (checked )
- Maximus live weight-loss program and promotional pricing (checked )
- Maximus tirzepatide individual product pricing page (checked )
- Maximus lab, refill and shipping process (checked )
- Maximus state restrictions for GLP-1 services (checked )
- Maximus customer experiences and independent Trustpilot ratings (checked )